LIFE EQUALITY ACT OF 2020
- Section 41-41-401 - Title
- Section 41-41-403 - Legislative findings and purpose
- Section 41-41-405 - Definitions
- Section 41-41-407 - Abortion may not be performed because of race, sex, or genetic abnormality except in a medical emergency
- Section 41-41-409 - Reporting forms
- Section 41-41-411 - Criminal penalties
- Section 41-41-413 - Professional sanction and civil penalties
- Section 41-41-415 - Additional enforcement
- Section 41-41-417 - Construction
- Section 41-41-419 - Severability
- Section 41-41-NEW-001 - [Newly enacted section not yet numbered] [Effective 7/1/2024] [Definitions]
- Section 41-41-NEW-002 - [Newly enacted section not yet numbered] [Effective 7/1/2024] [Provision of individualized investigational drug, biological product, or device from an eligible facility or manufacturer operating within an eligible facility - Costs]
- Section 41-41-NEW-003 - [Newly enacted section not yet numbered] [Effective 7/1/2024] [Construction of act]
- Section 41-41-NEW-004 - [Newly enacted section not yet numbered] [Effective 7/1/2024] [Patient death proximately caused by treatment with individualized investigational drug, biological product, or device - No liability for costs of treatment for estate, heirs]
- Section 41-41-NEW-005 - [Newly enacted section not yet numbered] [Effective 7/1/2024] [Prohibition against adverse licensure actions or Medicaid certification]
- Section 41-41-NEW-006 - [Newly enacted section not yet numbered] [Effective 7/1/2024] [State may not block eligible patient's access to an individualized investigational drug, biological product, or device - Acts not considered violations]
- Section 41-41-NEW-007 - [Newly enacted section not yet numbered] [Effective 7/1/2024] [No private cause of action created]
- Section 41-41-NEW-008 - [Newly enacted section not yet numbered] [Effective 7/1/2024] [Severability]